Anti-TIGIT antibody
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Anti-TIGIT antibody, covering 2025-02-14 to 2025-02-14. Get the full timeline:
Most recent: Clinical Trial Update: Immuno-Oncology Drugs Elotuzumab, Anti-LAG-3 and Anti-TIGIT [Phase 1, Phase 2]